Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04
Published May 10, 2017 · Recall initiated: December 27, 2016
Summary
FDA records drug Class III recall D-0692-2017, published May 10, 2017 and initiated December 27, 2016. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 36,990 tablets; Lot: LOT: T-00601 Exp: 04-2017. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug; out of specification results for assay (manufacturer)
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Harvard Drug Group
- Distributor
- Nationwide and PR
- Lot
- LOT: T-00601 Exp: 04-2017
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: SunJuly 5, 2023
- FDAGabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), RxMay 17, 2023
- FDACarbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in CzechMarch 8, 2023
- FDAhydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by:March 23, 2022
- FDAEpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P.,May 10, 2017
- FDARabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65162-0724-03), b) 90-count bottleMay 10, 2017
Questions about this recall
Was Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04 recalled?
Yes. FDA published recall D-0692-2017 on May 10, 2017. Reported hazard: Superpotent Drug; out of specification results for assay (manufacturer)
What should I do if I have this product?
Voluntary: Firm initiated · Letter